Journal profile · Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
Pharmacological Research Modern Chinese Medicine
ISSN 2667-1425 · Elsevier · Netherlands
Pharmacological Research Modern Chinese Medicine: impact factor 12.2 (journal website); diamond open access (no APC); no APC; review about 64 days (submission to acceptance, publisher); 166 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Pharmacological Research Modern Chinese Medicine is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Pharmacological Effects of Natural Compounds, Traditional Chinese Medicine Analysis and Natural Antidiabetic Agents Studies, together about 26.5% of its articles. Its main subfields are Complementary and alternative medicine. (generated from OpenAlex topic counts and CAS ranking data)
Affiliated with the 'Chinese Pharmacological Society', he journal Pharmacological Research - Modern Chinese Medicine (PRMCM) publishes articles reporting on advances in our comprehension of mechanism and safety in experimental pharmacology and clinical efficacy and safety of pharmacologically active substances, including compound prescriptions, utilized in Traditional Chinese Medicine applying modern scientific research methods. Studies reporting also on the mechanisms of actions of the active substance(s) investigated are encouraged.Reports must be on standardized preparations in which the ingredients are defined; elucidation of which are the active principles and which pathways they trigger is encouraged but not mandatory.The diseases investigated must be classified according to the WHO International Classification of Diseases version 11. Negative results will be considered.The Journal will not consider articles utilizing material from endangered species as categorized by the International Union for Conservation of Nature.Pharmacological Research - Modern Chinese Medicine (PRMCM) is an independent companion journal and a spin-off from Pharmacological Research (Pharmacol Res). It is part of the Pharmacological Research Family of Journals. PRMCM has an independent editorial team and will be indexed differently.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
Editor-in-chief Guanhua DuPublisher website
Editorial board by country: 85 in mainland China (about 85%); most named Mainland China 85, Macau, China 5, Italy 4, United States 2, Hong Kong, China 1 (100 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics12.2%
- Traditional Chinese Medicine AnalysisMedicine8%
- Natural Antidiabetic Agents StudiesMedicine6.3%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology6.1%
- Phytochemicals and Antioxidant ActivitiesMedicine5.4%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences4.7%
- Traditional Chinese Medicine StudiesMedicine4.7%
- Ginseng Biological Effects and ApplicationsBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CiteScorePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 12.2Publisher website ·
- CiteScore 2026-06
- 5.7LetPub ·
- CiteScore (publisher)
- 5.7Publisher website ·
- SJR 2026-06
- 0.56LetPub ·
- SNIP 2026-06
- 0.81LetPub ·
- h-index
- 33OpenAlex ·
- i10-index
- 177OpenAlex ·
- 2-year mean citedness
- 3.76OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 829 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 119 | 119 | 52 |
| 2025 | 166 | 166 | 375 |
| 2024 | 211 | 211 | 1,439 |
| 2023 | 135 | 135 | 1,556 |
| 2022 | 163 | 163 | 1,523 |
| 2021 | 35 | 35 | 412 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
64 dayssubmission to acceptance · community reports about 10 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 27 daysPublisher website ·
- Submission to acceptance
- 64 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 1,550 / EUR 1,450 / GBP 1,240 / JPY 192,250 | — | — | |
| LetPub | USD 1,400 | Yes | — | |
| Publisher website | USD 2,380 | — | — |
Other charges and waivers (author guidelines)
- Other fees
- Charged; see the journal's website for the amount
- Page charges
- Charged; see the journal's website for the amount
- Submission fee
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required
- Highlights
- Optional
- Graphical abstract
- Required
- Not considered
- case reports
Article types accepted12
- case reportOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- graphical reviewsGraphical Reviews. These reviews will summarize schematically key concepts, established and novel ideas which will be accessible to a broad audience and freely …Length not stated
- letters to the editorLetters to the Editor on relevant issues of pharmacology or commenting on the literature published in this journal or in Pharmacological Research - Modern Chine…Length not stated
- meta-analysisOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- original articleOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- original articlesOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- regular paperOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- research paperOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- reviewOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- review articleOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
- review articles and meta-analysesReview articles and meta-analyses. Review articles and meta-analyses are welcome but should be topical and not just an overview of the literature.Length not stated
- short communicationOriginal articles. Original full-length research papers that have not been published previously, except in a preliminary form, may be submitted as regular paper…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Author contributions
For transparency, we require corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration;…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open Access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; contributions initially assessed by editor; suitable papers sent to minimum of two independent expert reviewers. Model summary
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time; sharing preprints will not count as prior publication. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2667-1425
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Pharmacological Research Modern Chinese Medicine
What is the impact factor of Pharmacological Research Modern Chinese Medicine?
The journal's website gives an impact factor of 12.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 5.7, h-index 33.
How long does peer review take at Pharmacological Research Modern Chinese Medicine?
The publisher reports about 64 days (submission to acceptance); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pharmacological Research Modern Chinese Medicine?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Suggested reviewers: Required; Highlights: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pharmacological Research Modern Chinese Medicine based?
Of the 100 board members whose country the journal's board page names, 85 (about 85%) are in mainland China; the countries named most often are Mainland China (85), Macau, China (5) and Italy (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmacological Research Modern Chinese Medicine?
According to LetPub and DOAJ records, Pharmacological Research Modern Chinese Medicine is indexed in Scopus and DOAJ.
Is Pharmacological Research Modern Chinese Medicine open access, and what is the APC?
Pharmacological Research Modern Chinese Medicine is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .